Text this: CLINICAL AND PHARMACOECONOMIC ASPECTS OF ACTIVE CONTROLLED ANTI-INFLAMMATORY THERAPY OF RHEUMATOID ARTHRITIS, BASED ON THE PRINCIPLES OF THE «TREAT-TO-TARGET» STRATEGY: CURRENT STATE OF THE ISSUE